BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25097040)

  • 1. HRAS mutations are frequent in inverted urothelial neoplasms.
    McDaniel AS; Zhai Y; Cho KR; Dhanasekaran SM; Montgomery JS; Palapattu G; Siddiqui J; Morgan T; Alva A; Weizer A; Lee CT; Chinnaiyan AM; Quist MJ; Grasso CS; Tomlins SA; Mehra R
    Hum Pathol; 2014 Sep; 45(9):1957-65. PubMed ID: 25097040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomic landscape of inverted urothelial papilloma and urothelial papilloma of the bladder.
    Isharwal S; Hu W; Sarungbam J; Chen YB; Gopalan A; Fine SW; Tickoo SK; Sirintrapun SJ; Jadallah S; Loo FL; Pietzak EJ; Cha EK; Bochner BH; Berger MF; Iyer G; Solit DB; Reuter VE; Al-Ahmadie H
    J Pathol; 2019 Jul; 248(3):260-265. PubMed ID: 30838648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological significance of TERT promoter mutation in papillary urothelial neoplasm of low malignant potential.
    Wang CC; Huang CY; Jhuang YL; Chen CC; Jeng YM
    Histopathology; 2018 Apr; 72(5):795-803. PubMed ID: 29193225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urothelial hyperplastic lesion with endophytic growth pattern: a clinicopathologic study].
    Xiao L; Wang CF; Zhu XZ; Yin YL; Chen Y; Lu C; Yu B
    Zhonghua Bing Li Xue Za Zhi; 2011 May; 40(5):319-23. PubMed ID: 21756826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus is not an etiologic agent of urothelial inverted papillomas.
    Alexander RE; Davidson DD; Lopez-Beltran A; Montironi R; MacLennan GT; Compérat E; Idrees MT; Emerson RE; Cheng L
    Am J Surg Pathol; 2013 Aug; 37(8):1223-8. PubMed ID: 23681080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent KRAS and HRAS mutations in squamous cell papillomas of the head and neck.
    Sasaki E; Masago K; Fujita S; Hanai N; Yatabe Y
    J Pathol Clin Res; 2020 Apr; 6(2):154-159. PubMed ID: 31960612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
    Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
    Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating HRAS mutation in a case of inverted ductal papilloma of the salivary gland.
    Ide F; Ito Y; Kikuchi K; Satomura K; Ogawa I; Yamamoto H
    Pathol Int; 2021 Dec; 71(12):844-848. PubMed ID: 34547823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
    Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
    Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.
    Jones TD; Zhang S; Lopez-Beltran A; Eble JN; Sung MT; MacLennan GT; Montironi R; Tan PH; Zheng S; Baldridge LA; Cheng L
    Am J Surg Pathol; 2007 Dec; 31(12):1861-7. PubMed ID: 18043040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAS Family Gene Mutations, Clinicopathological Features, and Spread Patterns of Inverted Urothelial Papilloma of the Bladder.
    Kitahama K; Shigematsu Y; Amori G; Sugawara E; Yonese J; Shibahara J; Takeuchi K; Inamura K
    Am J Surg Pathol; 2024 Apr; 48(4):458-464. PubMed ID: 38145408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
    Cheng L; Davidson DD; Wang M; Lopez-Beltran A; Montironi R; Wang L; Tan PH; MacLennan GT; Williamson SR; Zhang S
    Histopathology; 2016 Jul; 69(1):107-13. PubMed ID: 26679899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus and Epstein-Barr virus in sinonasal Schneiderian papillomas. An in situ hybridization and polymerase chain reaction study.
    Gaffey MJ; Frierson HF; Weiss LM; Barber CM; Baber GB; Stoler MH
    Am J Clin Pathol; 1996 Oct; 106(4):475-82. PubMed ID: 8853035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inverted urothelial papilloma of the urinary bladder with focal papillary pattern: a previously undescribed feature.
    Albores-Saavedra J; Chable-Montero F; Hernández-Rodríguez OX; Montante-Montes de Oca D; Angeles-Angeles A
    Ann Diagn Pathol; 2009 Jun; 13(3):158-61. PubMed ID: 19433293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus (HPV) in sinonasal papillomas: a study of 78 cases using in situ hybridization and polymerase chain reaction.
    Buchwald C; Franzmann MB; Jacobsen GK; Lindeberg H
    Laryngoscope; 1995 Jan; 105(1):66-71. PubMed ID: 7837916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urothelial lesions with inverted growth patterns: histogenesis, molecular genetic findings, differential diagnosis and clinical management.
    Hodges KB; Lopez-Beltran A; Maclennan GT; Montironi R; Cheng L
    BJU Int; 2011 Feb; 107(4):532-7. PubMed ID: 21091975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverted papilloma of the bladder: a review and an analysis of the recent literature of 365 patients.
    Picozzi S; Casellato S; Bozzini G; Ratti D; Macchi A; Rubino B; Pace G; Carmignani L
    Urol Oncol; 2013 Nov; 31(8):1584-90. PubMed ID: 22520573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of six types of human papillomavirus in inverted papilloma and papillary transitional cell carcinoma of the bladder: an evaluation by polymerase chain reaction.
    Chan KW; Wong KY; Srivastava G
    J Clin Pathol; 1997 Dec; 50(12):1018-21. PubMed ID: 9516885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FGFR3 and TP53 mutation analysis in inverted urothelial papilloma: incidence and etiological considerations.
    Lott S; Wang M; Zhang S; MacLennan GT; Lopez-Beltran A; Montironi R; Sung MT; Tan PH; Cheng L
    Mod Pathol; 2009 May; 22(5):627-32. PubMed ID: 19287463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere shortening distinguishes inverted urothelial neoplasms.
    Williamson SR; Zhang S; Lopez-Beltran A; Montironi R; Wang M; Cheng L
    Histopathology; 2013 Mar; 62(4):595-601. PubMed ID: 23379729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.